UBS upgraded Altria Group (MO) to Buy from Neutral with a price target of $63, up from $61. The firm believes the worst of Altria’s cigarette volume decline could be behind the company. It expects an improvement in 2026 amid better industry volumes and price investment that could stabilize the company’s volume share. UBS cites better earnings visibility for the upgrade.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MO:
- Altria Group: Improving Fundamentals, EPS Acceleration, and Discounted Valuation Support Buy Rating
- Should Investors Buy High-Yield Dividend Stock Altria (MO) in 2026?
- Price and Dividend Combo Make Altria Stock (MO) a Worthy Contender in 2026
- Altria approval of on! PLUS a positive catalyst, says Goldman Sachs
- The Week That Was, The Week Ahead: Macro & Markets, Dec. 20